What compounds are in the KLOW Blend?

The KLOW Blend contains GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), and KPV (10mg). This combination is studied in research settings to explore potential synergies across tissue repair, vascular modulation, actin-based cellular processes, and anti-inflammatory pathways.

What is KPV and why is it included?

KPV is a tripeptide (Lys-Pro-Val) derived from the C-terminal of alpha-melanocyte stimulating hormone (alpha-MSH). It is studied for its potential anti-inflammatory properties and possible effects on gut mucosal integrity. Research in preclinical models has examined its interactions with NF-kB signaling pathways.

How does the KLOW Blend differ from the GLOW Blend?

The KLOW Blend extends the GLOW Blend formulation by adding KPV, a peptide studied for anti-inflammatory and gut-barrier properties. While both blends share GHK-Cu, BPC-157, and TB-500 as a core tissue-repair research matrix, KPV adds an immunomodulatory dimension to explore whether anti-inflammatory signaling intersects with the repair and regenerative mechanisms of the shared compounds.

Is the KLOW Blend for human use?

No. The KLOW Blend is strictly for research use only and is not intended for human consumption, therapeutic application, or diagnostic purposes. All compounds in this blend are for investigational and laboratory research applications only.

Every batch third-party verified

AUGE HEALTH

Research Area

KLOW Blend

A GHK-Cu, BPC-157, TB-500, and KPV research blend studied in tissue-repair and remodeling models.

Overview

The KLOW Blend category focuses on a diverse group of peptides being explored for their potential roles in various biological processes, including tissue repair, immune modulation, and cellular regeneration. These peptides are investigated primarily for their biochemical mechanisms and pathways rather than therapeutic effects.

The KLOW Blend encompasses compounds with distinct and potentially complementary mechanisms. GHK-Cu is studied for its influence on gene expression, particularly in relation to collagen and elastin production. BPC-157 is researched for its angiogenic properties and its capacity to modulate vascular signaling pathways involved in tissue repair. TB-500 is investigated for its role in actin polymerization and cellular motility. KPV — a tripeptide fragment of alpha-MSH — is studied for its potential anti-inflammatory and gut-barrier modulating properties. Together these four compounds represent an active area of preclinical research into the intersection of tissue remodeling and immunomodulatory signaling. All mechanisms are explored under research conditions without therapeutic claims.

Key Compounds

GHK-Cu

Studied for its effects on gene expression modulation and collagen synthesis.

BPC-157

Researched for its potential role in promoting tissue repair and angiogenesis.

TB-500

Explored for its actin-regulating properties and potential role in cellular repair and migration.

KPV

Investigated for its anti-inflammatory and gut-barrier modulating properties as an alpha-MSH fragment.

Research Questions

Research Q&A

For research use only. Nothing on this page constitutes a medical claim. These compounds are not intended for human or animal consumption. All content is grounded in published research literature and reviewed by our team.

← Back to Learn